Zoltán Czigler
Director of Finance/CFO bij Anergis SA
Profiel
Zoltán Czigler is currently the Chief Financial Officer at Anergis SA since 2011.
Prior to this, he worked as a Finance Director at Kuros Biosurgery Holding AG from 2004 to 2007.
He also worked as a Project Manager at Oracle Corp.
in 1999 and as an Investment Manager at Speed Ventures AB and VI Partners AG from 2000 to 2003.
Mr. Czigler holds an MBA from INSEAD and a graduate degree from Budapest University of Technology & Economics.
Actieve functies van Zoltán Czigler
Bedrijven | Functie | Begin |
---|---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Director of Finance/CFO | 01-04-2011 |
Eerdere bekende functies van Zoltán Czigler
Bedrijven | Functie | Einde |
---|---|---|
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Director of Finance/CFO | 01-01-2007 |
VI Partners AG
VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland. | Corporate Officer/Principal | 01-01-2003 |
Speed Ventures AB (Old) | Corporate Officer/Principal | 01-01-2003 |
ORACLE CORPORATION | Corporate Officer/Principal | 01-01-1999 |
Opleiding van Zoltán Czigler
INSEAD | Masters Business Admin |
Budapest University of Technology & Economics | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ORACLE CORPORATION | Technology Services |
Bedrijven in privébezit | 4 |
---|---|
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Speed Ventures AB (Old) | Finance |
VI Partners AG
VI Partners AG Investment ManagersFinance VI Partners AG (VI Partners) is an independent venture capital firm founded in 2001. The firm is headquartered in Schwyz, Switzerland. | Finance |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |